StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$2.06+0.10 (+5.10%)

Close on Nov 18, 2026Market cap $19.86MP/E –Yield –

Edesa Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Edesa Biotech

Edesa Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Edesa Biotech figures

See a number that looks wrong?